<!DOCTYPE html>
<html>

<!-- Mirrored from mullinslab.microbiol.washington.edu/publications/2264-Global-and-Regional-Estimates-for-Subtype-Specific-Therapeutic-and-Prophylactic-HIV-1-Vaccines-A-Modeling-Study by HTTrack Website Copier/3.x [XR&CO'2014], Mon, 21 Jul 2025 18:05:25 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
    
<title>Global and Regional Estimates for Subtype-Specific Therapeutic and Prophylactic HIV-1 Vaccines: A Modeling Study. | Mullins Molecular Retrovirology Lab</title>

    
    <link rel="stylesheet" href="style.css" />
    
    <link rel="alternate" type="application/atom+xml" title="Atom feed" href="feed" />
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <script src='https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js?config=TeX-MML-AM_CHTML' async></script>

    <!-- Global site tag (gtag.js) - Google Analytics -->
    <script async src="https://www.googletagmanager.com/gtag/js?id=UA-136625084-1"></script>
    <script>
      window.dataLayer = window.dataLayer || [];
      function gtag(){dataLayer.push(arguments);}
      gtag('js', new Date());

      gtag('config', 'UA-136625084-1');
    </script>
</head>
<body id="entry">

<div id="container">

<header>

<h1>Mullins Molecular Retrovirology Lab</h1>

<div class="description">
<ul>
<li>Department of Microbiology</li>
<li>School of Medicine</li>
<li>University of Washington</li>
</ul>

</div>


</header>

<section id="nav">
    <nav>
        
        <ul>
            <li class=""><a href="../index.html">Home</a></li>
            <li class=""><a href="../research/index.html">Research</a></li>
            <li class="here"><a href="index.html">Publications</a><ul><li><a href="supplemental.html">Supplemental Data</a></li></ul></li>
            <li class=""><a href="../protocols/index.html">Protocols</a></li>
            <li class=""><a href="../people/index.html">People</a></li>
            <li class=""><a href="../contact/index.html">Contact</a></li>
            <li class=""><a href="../help/index.html">Help</a></li>
        </ul>
    </nav>
</section>

<section id="links">
    <nav id="quicklinks">
        <h2>Software &amp; Tools</h2>

        <ul>
            <li><a href="http://indra.mullins.microbiol.washington.edu/">Bioinformatics Tools</a></li>
            <li><a href="https://github.com/mullinslab">GitHub</a></li>
            <li><a href="../hiris/index.html">HIRIS</a></li>
            <li><a href="../HMA/index.html">HMA Subtyping Kit</a></li>
            <li><a href="../isdb/index.html">ISDB</a></li>
            <li><a href="../tcozy/index.html">TCozy</a></li>
            <li><a href="https://viroverse.washington.edu/">Viroverse</a></li>
        </ul>
    </nav>

    <nav id="lablinks">
        <h2>Lab Links</h2>

        <ul>
            <li><a href="https://hercules.mullins.microbiol.washington.edu/pub/doc/">Computing Docs</a></li>
            <li><a href="../hiris/private/index.html">HIRIS (Private)</a></li>
            <li><a href="https://tcozy.mullins.microbiol.washington.edu/ice-floe/">ICE Floe</a></li>
            <li><a href="https://hercules.mullins.microbiol.washington.edu/git/">Internal Git</a></li>
            <li><a href="../twiki/index.html">Internal wiki</a></li>
            <li><a href="https://viroverse.washington.edu/viroblast/">Local ViroBLAST</a></li>
            <li><a href="https://redash.mullins.microbiol.washington.edu/">Redash</a></li>
            <li><a href="https://mullinslab.slack.com/">Slack</a></li>
            <li><a href="../support/index.html">Ticketing system</a></li>
        </ul>
    </nav>

</section>

<div id="cfar"><a href="http://cfar.washington.edu/">
    <img src="../static/_img/2c/47ca/CFAR-logo-rev-10-22-18_4aa6fe47bc_500x157.jpg" width="500" height="157" srcset="/static/_img/2c/47ca/CFAR-logo-rev-10-22-18_4aa6fe47bc_500x157.jpg 1x, /static/_img/2c/47ca/CFAR-logo-rev-10-22-18_4aa6fe47bc_1000x314.jpg 2x" alt="University of Washington/Fred Hutch Center for AIDS Research">
</a></div>

<section id="content">
    
<!-- source file: content/publications/34335516-Global-and-Regional-Estimates-for-Subtype-Specific-Therapeutic-and-Prophylactic-HIV-1-Vaccines-A-Modeling-Study.md -->
<article>

<div id="intro">
    <h1>Citation Information</h1>
<p>Elangovan R, Jenks M, Yun J, Dickson-Tetteh L, Kirtley S, Hemelaar J, WHO-UNAIDS Network for HIV Isolation and Characterisation (2021). <span class="title">Global and Regional Estimates for Subtype-Specific Therapeutic and Prophylactic HIV-1 Vaccines: A Modeling Study.</span> <cite class="journalName">Frontiers in microbiology</cite>, <span class="journalIssue">12</span>, 690647. (<a href="http://ncbi.nlm.nih.gov/pubmed/34335516">pubmed</a>) (<a href="https://doi.org/10.3389/fmicb.2021.690647">doi</a>)</p>
</div>


<div id="more">
    <h1>Abstract</h1>
<p>Global HIV-1 genetic diversity forms a major obstacle to the development of an HIV vaccine. It may be necessary to employ subtype-specific HIV-1 vaccines in individual countries according to their HIV-1 subtype distribution. We estimated the global and regional need for subtype-specific HIV-1 vaccines. We took into account the proportions of different HIV-1 variants circulating in each country, the genetic composition of HIV-1 recombinants, and the different genome segments (<i>gag</i>, <i>pol</i>, <i>env</i>) that may be incorporated into vaccines. We modeled different scenarios according to whether countries would employ subtype-specific HIV-1 vaccines against (1) the most common subtype; (2) subtypes contributing more than 5% of HIV infections; or (3) all circulating subtypes. For therapeutic vaccines targeting the most common HIV-1 subtype in each country, 16.5 million doses of subtype C vaccine were estimated globally, followed by subtypes A (14.3 million) and B (4.2 million). A vaccine based on <i>env</i> required 2.6 million subtype E doses, and a vaccine based on <i>pol</i> required 4.8 million subtype G doses. For prophylactic vaccines targeting the most common HIV-1 subtype in each country, 1.9 billion doses of subtype A vaccine were estimated globally, followed by subtype C (1.1 billion) and subtype B (1.0 billion). A vaccine based on <i>env</i> required 1.2 billion subtype E doses, and a vaccine based on <i>pol</i> required 0.3 billion subtype G doses. If subtype-specific HIV-1 vaccines are also directed against less common subtypes in each country, vaccines targeting subtypes D, F, H, and K are also needed and would require up to five times more vaccine doses in total. We conclude that to provide global coverage, subtype-specific HIV-1 vaccines need to be directed against subtypes A, B, and C. Vaccines targeting <i>env</i> also need to include subtype E and those targeting <i>pol</i> need to include subtype G.</p>
</div>


<div class="clear"></div>
</article>

</section>

</div>
</body>
<!-- Mirrored from mullinslab.microbiol.washington.edu/publications/2264-Global-and-Regional-Estimates-for-Subtype-Specific-Therapeutic-and-Prophylactic-HIV-1-Vaccines-A-Modeling-Study by HTTrack Website Copier/3.x [XR&CO'2014], Mon, 21 Jul 2025 18:05:25 GMT -->
</html>